These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32838256)

  • 21. Artificial Intelligence-Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device.
    Giudicessi JR; Schram M; Bos JM; Galloway CD; Shreibati JB; Johnson PW; Carter RE; Disrud LW; Kleiman R; Attia ZI; Noseworthy PA; Friedman PA; Albert DE; Ackerman MJ
    Circulation; 2021 Mar; 143(13):1274-1286. PubMed ID: 33517677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Retrospective Analysis of Hospital Electrocardiogram Auto-Populated QT Interval Calculation.
    Rosenblum AL; Dremonas AC; Stockholm SC; Biondi NL
    Cureus; 2020 Jul; 12(7):e9317. PubMed ID: 32714713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.
    Trinkley KE; Page RL; Lien H; Yamanouye K; Tisdale JE
    Curr Med Res Opin; 2013 Dec; 29(12):1719-26. PubMed ID: 24020938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperglycemia is associated with corrected QT prolongation and mortality in acutely ill patients.
    Pickham D; Flowers E; Drew BJ
    J Cardiovasc Nurs; 2014; 29(3):264-70. PubMed ID: 23364575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and outcomes of long QTc in acute medical admissions.
    Mahmud R; Gray A; Nabeebaccus A; Whyte MB
    Int J Clin Pract; 2018 Nov; 72(11):e13250. PubMed ID: 30222237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin.
    Cipriani A; Zorzi A; Ceccato D; Capone F; Parolin M; Donato F; Fioretto P; Pesavento R; Previato L; Maffei P; Saller A; Avogaro A; Sarais C; Gregori D; Iliceto S; Vettor R
    Int J Cardiol; 2020 Oct; 316():280-284. PubMed ID: 32439366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacist monitoring of QTc interval-prolonging medications in critically ill medical patients: a pilot study.
    Ng TM; Bell AM; Hong C; Hara JM; Touchette DR; Danskey KN; Lindsay TT; Puumala SE
    Ann Pharmacother; 2008 Apr; 42(4):475-82. PubMed ID: 18319393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QTc abnormalities in deliberate self-poisoning with moclobemide.
    Downes MA; Whyte IM; Isbister GK
    Intern Med J; 2005 Jul; 35(7):388-91. PubMed ID: 15958107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "QT clock" to improve detection of QT prolongation in long QT syndrome patients.
    Page A; Aktas MK; Soyata T; Zareba W; Couderc JP
    Heart Rhythm; 2016 Jan; 13(1):190-8. PubMed ID: 26334569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and determinants of QT interval prolongation in medical inpatients.
    Pasquier M; Pantet O; Hugli O; Pruvot E; Buclin T; Waeber G; Aujesky D
    Intern Med J; 2012 Aug; 42(8):933-40. PubMed ID: 21299787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients.
    Russo V; Carbone A; Mottola FF; Mocerino R; Verde R; Attena E; Verde N; Di Micco P; Nunziata L; Santelli F; Nigro G; Severino S
    Front Pharmacol; 2020; 11():582348. PubMed ID: 33132915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-induced 'Torsade de Pointes' in a COVID-19 patient despite discontinuation of chloroquine. Importance of its long half-life: a case report.
    Semedo E; Kapel GF; van Opstal J; van Dessel PFHM
    Eur Heart J Case Rep; 2020 Oct; 4(FI1):1-5. PubMed ID: 33089050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying QT prolongation from ECG impressions using a general-purpose Natural Language Processor.
    Denny JC; Miller RA; Waitman LR; Arrieta MA; Peterson JF
    Int J Med Inform; 2009 Apr; 78 Suppl 1(Suppl 1):S34-42. PubMed ID: 18938105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-gender influence on the rate-corrected QT interval and the QT-heart rate relation in families with genotypically characterized long QT syndrome.
    Lehmann MH; Timothy KW; Frankovich D; Fromm BS; Keating M; Locati EH; Taggart RT; Towbin JA; Moss AJ; Schwartz PJ; Vincent GM
    J Am Coll Cardiol; 1997 Jan; 29(1):93-9. PubMed ID: 8996300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancer.
    Rowe EJ; Shugg T; Ly RC; Philips S; Rosenman MB; Callaghan JT; Radovich M; Overholser BR; Schneider BP; Tisdale JE; Skaar TC
    Front Cardiovasc Med; 2022; 9():894623. PubMed ID: 36588548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Orders for QTc-Prolonging Medication for Intensive and Cardiac Care Unit Patients with Pre-existing QTc Prolongation (QTIPPP Study).
    Mabasa VH; Yokoyama S; Man D; Martyn J
    Can J Hosp Pharm; 2011 Nov; 64(6):412-8. PubMed ID: 22479096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychotropic drugs associated with corrected QT interval prolongation.
    van Noord C; Straus SM; Sturkenboom MC; Hofman A; Aarnoudse AJ; Bagnardi V; Kors JA; Newton-Cheh C; Witteman JC; Stricker BH
    J Clin Psychopharmacol; 2009 Feb; 29(1):9-15. PubMed ID: 19142100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. QT Prolongation in Cancer Patients.
    Kim P; Masha L; Olson A; Iliescu C; Karimzad K; Hassan S; Palaskas N; Durand JB; Leung CH; Lopez-Mattei J
    Front Cardiovasc Med; 2021; 8():613625. PubMed ID: 33718445
    [No Abstract]   [Full Text] [Related]  

  • 39. Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations.
    Carlsson L; Abrahamsson C; Andersson B; Duker G; Schiller-Linhardt G
    Cardiovasc Res; 1993 Dec; 27(12):2186-93. PubMed ID: 8313427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association between intravenous haloperidol and prolonged QT interval.
    Hatta K; Takahashi T; Nakamura H; Yamashiro H; Asukai N; Matsuzaki I; Yonezawa Y
    J Clin Psychopharmacol; 2001 Jun; 21(3):257-61. PubMed ID: 11386487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.